{"url_path":"/sec/kphmw/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1372514/0001372514-26-000047-index.html","accession_number":"0001372514-26-000047","cik":"0001372514","ticker":"KPRX","issuer_name":"KIORA PHARMACEUTICALS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1372514/0001372514-26-000047-index.html","primary_entity_key":"0001372514","primary_entity_name":"KIORA PHARMACEUTICALS INC"},"word_count":566,"has_tables":true,"body_markdown":"Item 6. Exhibits\n\nThe exhibits filed as part of this Quarterly Report on Form 10-Q are set forth on the Exhibit Index immediately preceding such exhibits and are incorporated herein by reference.\n\n9 Shares withheld to cover tax withholding obligations under net settlement provisions of restricted stock awards that vested during the period.\n\n34\n\n[Table of Contents](#i0c6f9439d9f548028359cf9328d1fd98_7)\n\nSIGNATURES\n\nPursuant to the requirements of Section 13 and 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.\n\nDate: May 8, 2026\nBy:/s/ Brian M. Strem, Ph.D.\n\nPresident and Chief Executive Officer\n(Principal executive officer)\n\nDate: May 8, 2026\nBy:/s/ Melissa Tosca\n\nChief Financial Officer\n\n(Principal financial and accounting officer)\n\n35\n\n[Table of Contents](#i0c6f9439d9f548028359cf9328d1fd98_7)\n\nEXHIBIT INDEX\n\nThe following exhibits are filed as part of this Quarterly Report on Form 10-Q. Where such filing is made by incorporation by reference to a previously filed document, such document is identified.\n\nExhibit\nNumberDescription of Exhibit\n\n4.1\n[Form of Pre-Funded Warrant](https://www.sec.gov/Archives/edgar/data/1372514/000137251426000036/ex41-kioraxpipexformofprex.htm)[(previously filed as an exhibit to the Regi](https://www.sec.gov/Archives/edgar/data/1372514/000137251426000036/ex41-kioraxpipexformofprex.htm)[strant's Cur](https://www.sec.gov/Archives/edgar/data/1372514/000137251426000036/ex41-kioraxpipexformofprex.htm)[rent Report on Form 8-K filed on April 7, 2026 and incorporated by reference thereto)](https://www.sec.gov/Archives/edgar/data/1372514/000137251426000036/ex41-kioraxpipexformofprex.htm)\n\n4.2\n[F](https://www.sec.gov/Archives/edgar/data/1372514/000137251426000036/ex42-kioraxpipexformoftran.htm)[orm of Tranche A-](https://www.sec.gov/Archives/edgar/data/1372514/000137251426000036/ex42-kioraxpipexformoftran.htm)[1 Warrant](https://www.sec.gov/Archives/edgar/data/1372514/000137251426000036/ex42-kioraxpipexformoftran.htm)[(previously filed as an exhibit to the Registrant's Current Report on Form 8-K filed on April 7, 2026 and incorporated by reference thereto)](https://www.sec.gov/Archives/edgar/data/1372514/000137251426000036/ex42-kioraxpipexformoftran.htm)\n\n4.3\nForm of Tranche A-2 Warrant (previously filed as an exhibit to the Registrant's Current Report on Form 8-K filed on April 7, 2026 and incorporated by reference thereto)\n\n10.1†\n\n[F](https://www.sec.gov/Archives/edgar/data/1372514/000137251426000036/ex101-kioraxpipexsecuritie.htm)[orm of Securities Purchase](https://www.sec.gov/Archives/edgar/data/1372514/000137251426000036/ex101-kioraxpipexsecuritie.htm)[Agreement, dated as o](https://www.sec.gov/Archives/edgar/data/1372514/000137251426000036/ex101-kioraxpipexsecuritie.htm)[f April 3, 2026,](https://www.sec.gov/Archives/edgar/data/1372514/000137251426000036/ex101-kioraxpipexsecuritie.htm)[among Kiora Pharmaceuticals, Inc. and the purchasers named therein](https://www.sec.gov/Archives/edgar/data/1372514/000137251426000036/ex101-kioraxpipexsecuritie.htm)[(previously filed as an exhibit to the Registrant's Current Report on Form 8-K filed on April 7, 2026 and incorporated by reference thereto)](https://www.sec.gov/Archives/edgar/data/1372514/000137251426000036/ex101-kioraxpipexsecuritie.htm)\n\n10.2†\n\n[F](https://www.sec.gov/Archives/edgar/data/1372514/000137251426000036/ex102-kioraxpipexregistrat.htm)[orm of Registration Rights Agreement](https://www.sec.gov/Archives/edgar/data/1372514/000137251426000036/ex102-kioraxpipexregistrat.htm)[dated as of April 3, 2026, among Kiora Pharmaceuticals, Inc. and the](https://www.sec.gov/Archives/edgar/data/1372514/000137251426000036/ex102-kioraxpipexregistrat.htm)[holders](https://www.sec.gov/Archives/edgar/data/1372514/000137251426000036/ex102-kioraxpipexregistrat.htm)[named therein](https://www.sec.gov/Archives/edgar/data/1372514/000137251426000036/ex102-kioraxpipexregistrat.htm)[(previously filed as an exhibit to the Registrant's Current Report on Form 8-K filed on April 7, 2026 and incorporated by reference thereto)](https://www.sec.gov/Archives/edgar/data/1372514/000137251426000036/ex102-kioraxpipexregistrat.htm)\n\n31.1\n[Certification of principal executive officer pursuant to Rules 13a-15(e) and 15d-15(e), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](kprx-20260331xexx311.htm)\n\n31.2\n[Certification of principal financial and accounting officer pursuant to Rules 13a-15(e) and 15d-15(e), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](kprx-20260331xexx312.htm)\n\n32.1*\n\n[Certification of principal executive officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](kprx-20260331xexx321.htm)\n\n32.2*\n\n[Certification of principal financial and accounting officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](kprx-20260331xexx322.htm)\n\n101.INSXBRL Instance Document (embedded within the Inline XBRL document)\n\n101.SCHXBRL Taxonomy Extension Schema Document\n\n101.CALXBRL Taxonomy Extension Calculation Linkbase Document\n\n101.DEFXBRL Taxonomy Extension Definition Linkbase Document\n\n101.LABXBRL Taxonomy Extension Labels Linkbase Document\n\n101.PREXBRL Taxonomy Extension Presentation Linkbase Document\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document)\n\n______________________________\n\n*    This certification shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act.\n\n†    Schedules and exhibits have been omitted from this exhibit pursuant to Item 601(a)(5) of Regulation S-K. The registrant hereby undertakes to furnish copies of any of the omitted schedules and exhibits upon request by the U.S. Securities and Exchange Commission.\n\n36"}